3D Printed Drugs Market Report 2019 - 2026, Growth Trend, Revenue, Sales Volume, Estimation and Forecast

By Spritam, By Scenario (low growth, moderate growth, and rapid growth), By Region(North America, Europe, APAC and Rest of the World)

LATEST: This report includes COVID 19 Impact Analysis of the Market

  • Report ID : MD1244
  • |
  • Pages : 191
  • |
  • Tables : 91
  • |
  • Formats :

3D Printed Drugs market revenue is estimated to be $XX Billion in 2018 and shall grow with a CAGR of XX.X% during the forecast period of 2018 to 2026.

These drugs are manufactured by the 3D printing process to treat dysphagia. The rising problems of epilepsy are anticipated to fuel up the market revenue significantly over the forecast period. Further, the enhanced features of these drugs such as instant solubility in water are and the increasing development in 3D printing technology and increasing awareness among the consumers about this technology is also contributing significantly to boosting up the 3D printed market sales. However, the lack of laws and regulations regarding 3D printing technology is likely to hamper market growth shortly. Moreover, the customizable nature of the 3D printed drugs is anticipated to augment the market shares significantly over the forecast period.

One of the main reasons responsible for the growth of the 3D printed drugs market is the wide range of advantages associated with 3D printed drugs. With the help of 3D printing electronics, it possible to produce the electronic components of compact size. The industries where there is a lack of space get sufficient benefits from such kind of technology. Further, the electronic components produced by 3D printing technology are highly efficient, lightweight and provide the facility of more efficient design. Furthermore, electronic components such as sensors and antennas can be directly printed on the 3D surfaces which eliminate the need for circuitry. All these advantages provided by 3D printed drugs are contributing substantially to affect the 3D printed drugs market trend positively.

The rapid development of medical infrastructure in the Asia Pacific region is expected to fuel up the 3D printed drugs market revenue:

North America region is the dominant region in contributing to the market growth in 2018. The rising investment by the industry players of the region is driving the shares of the market in the region. Further, this region is anticipated to fuel up the market shares significantly over the forecast period owing to the increasing development of the pharmaceutical infrastructure in the region. Moreover, the Europe region is also anticipated to grow significantly over the forecast period owing to the heavy competition among the industry players in these regions.

Spritam 3D printed drug is expected to support market growth during the forecast period:

Based on a growth scenario, the market has been segmented as low growth, moderate growth, and rapid growth. The Spritam is the only drug that has been approved by the FDA until now. These drugs are used for the treatment of epilepsy. It was developed by the Aprecia Pharmaceuticals. Further, the growth scenario segment is anticipated to grow at a CAGR of 6.5% over the forecast period.

3D Printed Drugs industry Players:

Major industry players have been analyzed with coverage on their operating areas, revenues, and other strategic aspects. Further, the increasing number of industry players investing in this market especially from the Asia Pacific region is anticipated to affect the 3D printed drugs market positively over the forecast period. These industry players include Aprecia Pharmaceuticals, LLC, 3D Printer Drug Machine, FabRx Ltd., GlaxoSmithKline Plc. Hewlett Packard Caribe, BV, National University of Singapore, University College London, University of Glasgow, The University of Nottingham and UCL School of Pharmacy.

Key Points Covered in the Report:
        

•    Revenue Estimation and Forecast (2018 – 2026)
•    Production Estimation and Forecast (2018 – 2026)
•    Sales/Consumption Volume Estimation and Forecast (2018 – 2026)
•    Breakdown of Revenue by Segments (2018 – 2026)
•    Breakdown of Production by Segments (2018 – 2026)
•    Breakdown of Sales Volume by Segments (2018 – 2026)
•    Gross Margin and Profitability Analysis of Companies
•    Business Trend and Expansion Analysis
•    Import and Export Analysis
•    Regional Analysis and Data Breakdown

MARKET SEGMENTATION

By Spritam Outlook ($Revenue and unit sales, 2018-2026)

•    Rest of the World
•    The U.S.

By Scenario Outlook ($Revenueand unit sales, 2018-2026)

•    Moderate growth 
•    Rapid growth
•    Low growth

By Regional Outlook ($Revenueand unit sales, 2018-2026)

•    North America
•    Canada
•    U.S
•    Mexico
•    Europe
•    Germany
•    France
•    U.K
•    Rest of Europe 
•    Asia-Pacific
•    China
•    India
•    Japan
•    Rest of Asia Pacific
•    Rest of the World
•    The Middle East and Africa
•    Latin America

3D Printed Drugs Market Players:

•    Aprecia Pharmaceuticals
•    LLC
•    3D Printer Drug Machine
•    FabRx Ltd.
•    GlaxoSmithKline Plc.
•    Hewlett Packard Caribe, BV
•    National University of Singapore
•    University College London
•    University of Glasgow
•    The University of Nottingham
•    UCL School of Pharmacy

CHAPTER 1:    INTRODUCTION

1.1. Research Methodology

1.1.1. Desk Research

1.1.2. Data Synthesis

1.1.3. Data Validation & Market Feedback

1.1.4. Data Sources

CHAPTER 2:    EXECUTIVE SUMMARY

2.1. Global Market Outlook

2.2. Core Insights - Spritam

2.3. Core Insights – Scenario

2.4. Core Insights – Geography

CHAPTER 3:    MARKET OVERVIEW

3.1.  Market Definition and Scope

3.2. Key Forces Shaping the Industry

3.2.1. Bargaining Power of Suppliers

3.2.2. Bargaining Power of Buyers

3.2.3. Threat of Substitutes

3.2.4. Threat of New Entrants

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Supply-side Drivers

3.3.1.2. Demand-side Drivers

3.3.2. Restraints

3.3.3. Opportunities

3.4. Industry Landscape - PESTEL Analysis

3.4.1. Political Landscape

3.4.2. Environmental Landscape

3.4.3. Social Landscape

3.4.4. Technology Landscape

3.4.5. Economic Landscape

CHAPTER 4:    MARKET BACKGROUND

4.1. Industry Value Chain Analysis

4.1.1. Upstream Participants

4.1.2. Downstream participants

4.2. Pricing Analysis and Forecast, 2018-2026

4.2.1. By Type

4.2.2. By Region

CHAPTER 5:    GLOBAL 3D PRINTED DRUGS MARKET, BY SPRITAM

5.1. Overview

5.1.1. Market Volume and Forecast, 2018-2026

5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

5.2. Rest of the World

5.2.1. Key Market Trends, Growth Factors and Opportunities

5.2.2. Market Volume and Forecast, By Region

5.2.3. Market Revenue (US$ Million) and Forecast, By Region

5.3. The U.S.

5.3.1. Key Market Trends, Growth Factors and Opportunities

5.3.2. Market Volume and Forecast, By Region

5.3.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 6:    GLOBAL 3D PRINTED DRUGS MARKET, BY SCENARIO

6.1. Overview

6.1.1. Market Volume and Forecast, 2018-2026

6.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

6.2. Moderate growth

6.2.1. Key Market Trends, Growth Factors and Opportunities

6.2.2. Market Volume and Forecast, By Region

6.2.3. Market Revenue (US$ Million) and Forecast, By Region

6.3. Rapid growth

6.3.1. Key Market Trends, Growth Factors and Opportunities

6.3.2. Market Volume and Forecast, By Region

6.3.3. Market Revenue (US$ Million) and Forecast, By Region

6.4. Low growth

6.4.1. Key Market Trends, Growth Factors and Opportunities

6.4.2. Market Volume and Forecast, By Region

6.4.3. Market Revenue (US$ Million) and Forecast, By Region        

CHAPTER 7:    GLOBAL 3D PRINTED DRUGS MARKET, BY GEOGRAPHY

7.1. Overview

7.2. North America

7.2.1. Key Market Trends, Growth Factors and Opportunities

7.2.2. Market Volume and Forecast, By Spritam

7.2.3. Market Volume and Forecast, By Scenario

7.2.4. Market Revenue and Forecast, By Spritam

7.2.5. Market Revenue and Forecast, By Scenario

7.2.6. Market Revenue and Forecast, By Country

7.2.7. U.S.

7.2.7.1. Market Volume and Forecast

7.2.7.2. Market Revenue and Forecast

7.2.8. Canada

7.2.8.1. Market Volume and Forecast

7.2.8.2. Market Revenue and Forecast

7.2.9. Mexico

7.2.9.1. Market Volume and Forecast

7.2.9.2. Market Revenue and Forecast

7.3. Europe

7.3.1. Market Volume and Forecast, By Spritam

7.3.2. Market Volume and Forecast, By Scenario

7.3.3. Market Revenue and Forecast, By Spritam

7.3.4. Market Revenue and Forecast, By Scenario

7.3.5. Market Revenue and Forecast, By Country

7.3.6. Germany

7.3.6.1. Market Volume and Forecast, By Spritam

7.3.6.2. Market Revenue and Forecast, By Scenario

7.3.7. UK

7.3.7.1. Market Volume and Forecast, By Spritam

7.3.7.2. Market Revenue and Forecast, By Scenario

7.3.8. France

7.3.8.1. Market Volume and Forecast, By Spritam

7.3.8.2. Market Revenue and Forecast, By Scenario

7.3.9. Italy

7.3.9.1. Market Volume and Forecast, By Spritam

7.3.9.2. Market Revenue and Forecast, By Scenario

7.3.10. Rest of Europe

7.3.10.1. Market Volume and Forecast, By Spritam

7.3.10.2. Market Revenue and Forecast, By Scenario

7.4. Asia-Pacific

7.4.1. Market Volume and Forecast, By Spritam

7.4.2. Market Volume and Forecast, By Scenario

7.4.3. Market Revenue and Forecast, By Spritam

7.4.4. Market Revenue and Forecast, By Scenario

7.4.5. Market Revenue and Forecast, By Country

7.4.6. China

7.4.6.1. Market Volume and Forecast, By Spritam

7.4.6.2. Market Revenue and Forecast, By Scenario

7.4.7. India

7.4.7.1. Market Volume and Forecast, By Spritam

7.4.7.2. Market Revenue and Forecast, By Scenario

7.4.8. Japan

7.4.8.1. Market Volume and Forecast, By Spritam

7.4.8.2. Market Revenue and Forecast, By Scenario

7.4.9. South Korea

7.4.9.1. Market Volume and Forecast, By Spritam

7.4.9.2. Market Revenue and Forecast, By Scenario

7.4.10. Rest of Asia-Pacific

7.4.10.1. Market Volume and Forecast, By Spritam

7.4.10.2. Market Revenue and Forecast, By Scenario

7.5. REST OF THE WORLD

7.5.1. Market Volume and Forecast, By Spritam

7.5.2. Market Volume and Forecast, By Scenario

7.5.3. Market Revenue and Forecast, By Spritam

7.5.4. Market Revenue and Forecast, By Scenario

7.5.5. Market Revenue and Forecast, By Country

7.5.6. Latin America

7.5.6.1. Market Volume and Forecast, By Spritam

7.5.6.2. Market Revenue and Forecast, By Scenario

7.5.7. Middle East

7.5.7.1. Market Volume and Forecast, By Spritam

7.5.7.2. Market Revenue and Forecast, By Scenario

7.5.8. Africa

7.5.8.1. Market Volume and Forecast, By Spritam

7.5.8.2. Market Revenue and Forecast, By Scenario

CHAPTER 8:    COMPETITIVE LANDSCAPE

8.1. 3D Printed Drugs Market Share Analysis, 2018

CHAPTER 9:    COMPANY PROFILES

9.1. Aprecia Pharmaceuticals

9.1.1. Company Overview

9.1.2. Financial Performance

9.1.3. SWOT Analysis

9.2. LLC

9.2.1. Company Overview

9.2.2. Financial Performance

9.2.3. SWOT Analysis

9.3. 3D Printer Drug Machine

9.3.1. Company Overview

9.3.2. Financial Performance

9.3.3. SWOT Analysis

9.4. FabRx Ltd.

9.4.1. Company Overview

9.4.2. Financial Performance

9.4.3. SWOT Analysis

9.5. GlaxoSmithKline Plc.

9.5.1. Company Overview

9.5.2. Financial Performance

9.5.3. SWOT Analysis

9.6. Hewlett Packard Caribe, BV

9.6.1. Company Overview

9.6.2. Financial Performance

9.6.3. SWOT Analysis

9.7. National University of Singapore

9.7.1. Company Overview

9.7.2. Financial Performance

9.7.3. SWOT Analysis

9.8. University College London

9.8.1. Company Overview

9.8.2. Financial Performance

9.8.3. SWOT Analysis

9.9. University of Glasgow

9.9.1. Company Overview

9.9.2. Financial Performance

9.9.3. SWOT Analysis

9.10. The University of Nottingham

9.10.1. Company Overview

9.10.2. Financial Performance

9.10.3. SWOT Analysis

9.11. UCL School of Pharmacy

9.11.1. Company Overview

9.11.2. Financial Performance

9.11.3. SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com